XML 37 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements (Tables)
6 Months Ended
Nov. 30, 2018
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present information about the Company’s financial assets measured at fair value on a recurring basis as of November 30, 2018 and May 31, 2018, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
 
 
As of November 30, 2018
(In millions)
 
Assets at Fair Value
 
Cash and Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
481

 
$
481

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
359

 

 
359

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
1,421

 
1,318

 
103

 

U.S. Agency securities
 
52

 
50

 
2

 

Commercial paper and bonds
 
205

 
51

 
154

 

Money market funds
 
1,523

 
1,523

 

 

Total Level 2:
 
3,201

 
2,942

 
259

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
11

 

 

 
11

TOTAL
 
$
4,052

 
$
3,423

 
$
618

 
$
11


 
 
As of May 31, 2018
(In millions)
 
Assets at Fair Value
 
Cash and Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
415

 
$
415

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
1,178

 
500

 
678

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
925

 
907

 
18

 

U.S. Agency securities
 
102

 
100

 
2

 

Commercial paper and bonds
 
451

 
153

 
298

 

Money market funds
 
2,174

 
2,174

 

 

Total Level 2:
 
3,652

 
3,334

 
318

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
11

 

 

 
11

TOTAL
 
$
5,256

 
$
4,249

 
$
996

 
$
11

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following tables present information about the Company’s derivative assets and liabilities measured at fair value on a recurring basis as of November 30, 2018 and May 31, 2018, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
 
 
As of November 30, 2018
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
648

 
$
498

 
$
150

 
$
50

 
$
50

 
$

Embedded derivatives
 
8

 
2

 
6

 
8

 
3

 
5

TOTAL
 
$
656

 
$
500

 
$
156

 
$
58

 
$
53

 
$
5

(1)
If the foreign exchange derivative instruments had been netted on the Unaudited Condensed Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $46 million as of November 30, 2018. As of that date, the Company had received $259 million of cash collateral from various counterparties related to foreign exchange derivative instruments. No amount of collateral was posted on the Companys derivative liability balance as of November 30, 2018.
 
 
As of May 31, 2018
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
389

 
$
237

 
$
152

 
$
182

 
$
182

 
$

Embedded derivatives
 
11

 
3

 
8

 
8

 
2

 
6

TOTAL
 
$
400

 
$
240

 
$
160

 
$
190

 
$
184

 
$
6

(1)
If the foreign exchange derivative instruments had been netted on the Condensed Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $182 million as of May 31, 2018. As of that date, the Company had received $23 million of cash collateral from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Companys derivative liability balance as of May 31, 2018.
The following table presents the fair values of derivative instruments included within the Unaudited Condensed Consolidated Balance Sheets as of November 30, 2018 and May 31, 2018. Refer to Note 4 — Fair Value Measurements for a description of how the financial instruments in the table below are valued.
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Balance Sheet
Location
 
November 30,
2018
 
May 31,
2018
 
Balance Sheet 
Location
 
November 30,
2018
 
May 31,
2018
Derivatives formally designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
$
345

 
$
118

 
Accrued liabilities
 
$
10

 
$
156

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
140

 
152

 
Deferred income taxes and other liabilities
 

 

Total derivatives formally designated as hedging instruments
 
 
 
485

 
270

 
 
 
10

 
156

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
153

 
119

 
Accrued liabilities
 
40

 
26

Embedded derivatives
 
Prepaid expenses and other current assets
 
2

 
3

 
Accrued liabilities
 
3

 
2

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
10

 

 
Deferred income taxes and other liabilities
 

 

Embedded derivatives
 
Deferred income taxes and other assets
 
6

 
8

 
Deferred income taxes and other liabilities
 
5

 
6

Total derivatives not designated as hedging instruments
 
 
 
171

 
130

 
 
 
48

 
34

TOTAL DERIVATIVES
 
 
 
$
656

 
$
400

 
 
 
$
58

 
$
190